Topic: Venture Capital

Demand for ‘natural’ drives new $50M fund for early-stage Canadian tech companies

NPC Ventures is a $50-million investment fund for early-stage Canadian companies developing naturally-derived alternatives to synthetic products. The fund is led by Kristi Miller, who says she believes there exists a “tremendous opportunity for Canadian companies to meet this exponential demand for ‘natural’.”

The Short Report – March 17, 2021: Canadian government invests heavily to bolster biomanufacturing, D-Wave Systems gets funding for quantum tech, Canada’s largest study on aging gets a top-up, and more

The Government of Canada seeks to bolster Canada’s biomanufacturing capacity, D-Wave receives $40 million to accelerate Canada’s quantum technology development, the federal government invests in Canada’s longest-ever study on aging, Quebec’s Lion Electric gets ready to break ground on a new battery manufacturing plant, and more.

Alberta agri-food sector gets a boost with launch of new research and innovation network

A new $108.5-million technology and agri-food research and innovation network, supported by the federal government and industry, is expected to begin operations by the end of this month. Alberta Innovates’ Inventures conference also highlighted a new $40 funding challenge from Emissions Reduction Alberta to accelerate technology innovation in agriculture, agri-food and forestry.

The Short Report, May 13, 2020: Public trust in science rising; new COVID-19 advisory councils created; OneEleven ceases operations; and more

COVID-19 NEWS Canadians’ trust in doctors, scientists and the government has increased since the cornovirus pandemic began, finds public opinion polls from January and repeated on May 1 and May 2. Conducted by Proof Strategies CanTrust Index of Ottawa, the survey found that 76% of Canadians trusted doctors and 70% trusted scientists. The follow up…

The Short Report, May 6, 2020: AbCellera receives $175.6M for COVID-19 therapies; Canada contributes $850 million to global pandemic response; new “super angel” fund launches; and more

Vancouver-based AbCellera Biologics will receive up to $175.6 million from the federal Strategic Innovation Fund to fast-track antibody therapies against COVID-19. The funding will also go to build a first-of-its-kind antibody manufacturing facility over the next four years to help Canada respond to future pandemics. AbCellera has partnered with global biopharmaceutical company Eli Lilly to…